Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
for
Recurrent Melanoma (Skin), Metastatic Melanoma,
Location: Sarasota FL, Jacksonville FL, Miami FL, Chapel Hill NC,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05655312
Phase 1, Phase 2, Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Sarasota FL, Mobile AL, Atlanta GA, Birmingham AL,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Sarasota FL, West Palm Beach FL, Miami Beach FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Sarasota FL, Atlanta GA, Myrtle Beach SC, Nashville TN,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy